WO2004071433A3 - Procedes de traitement de maladie - Google Patents
Procedes de traitement de maladie Download PDFInfo
- Publication number
- WO2004071433A3 WO2004071433A3 PCT/US2004/003635 US2004003635W WO2004071433A3 WO 2004071433 A3 WO2004071433 A3 WO 2004071433A3 US 2004003635 W US2004003635 W US 2004003635W WO 2004071433 A3 WO2004071433 A3 WO 2004071433A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compounds
- methods
- compositions
- treating disease
- disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
Abstract
L'invention concerne des composés de guanidinyle substitué, des compositions contenant ces composés, et des procédés utilisant ces composés et les compositions à base de ces composés. Les composés, les compositions et les procédés décrits dans cette invention peuvent être utilisés dans la modulation thérapeutique de la fonction d'un canal ionique, et dans le traitement de maladies et de symptômes de maladie, notamment ceux induits par certaines cibles de sous-type de canal de calcium.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44660303P | 2003-02-11 | 2003-02-11 | |
US60/446,603 | 2003-02-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004071433A2 WO2004071433A2 (fr) | 2004-08-26 |
WO2004071433A3 true WO2004071433A3 (fr) | 2004-11-25 |
Family
ID=32869537
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/003635 WO2004071433A2 (fr) | 2003-02-11 | 2004-02-09 | Procedes de traitement de maladie |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2004071433A2 (fr) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5614630A (en) * | 1991-02-08 | 1997-03-25 | Cambridge Neuroscience, Inc. | Acenaphthyl substituted guanidines and methods of use thereof |
US5741661A (en) * | 1991-02-08 | 1998-04-21 | Cambridge Neuroscience, Inc. | Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers |
-
2004
- 2004-02-09 WO PCT/US2004/003635 patent/WO2004071433A2/fr active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5614630A (en) * | 1991-02-08 | 1997-03-25 | Cambridge Neuroscience, Inc. | Acenaphthyl substituted guanidines and methods of use thereof |
US5741661A (en) * | 1991-02-08 | 1998-04-21 | Cambridge Neuroscience, Inc. | Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers |
Also Published As
Publication number | Publication date |
---|---|
WO2004071433A2 (fr) | 2004-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005086836A3 (fr) | Modulateurs de canal ionique | |
WO2005086895A3 (fr) | Modulateurs de la fonction canal ionique | |
WO2005086902A3 (fr) | Modulateurs de canal ionique | |
WO2005097112A3 (fr) | Modulateurs de canaux ioniques | |
WO2008033562A3 (fr) | Composés inhibiteurs de kinases | |
WO2005086656A3 (fr) | Derives d'heteroarylaminopyrazole utilises pour traiter le diabete | |
WO2006086562A3 (fr) | Derives de phenylazetidinone | |
EA200700225A1 (ru) | Аналоги тетрапептида | |
WO2006102504A3 (fr) | Combinaisons destinees au traitement de cancer | |
WO2006042249A3 (fr) | Methodes et compositions de traitement de la douleur de migraine | |
WO2006044775A3 (fr) | Preparation et utilisation de derives de biphenyl-4-yl-carbonylamino-acide dans le traitement de l'obesite | |
WO2007016538A3 (fr) | Preparation et utilisation de derives aminoacides biphenyle pour traiter l'obesite | |
TW200608979A (en) | Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | |
WO2004100881A3 (fr) | Preparation et utilisation de derives d'aryl alkyl acide pour le traitement de l'obesite | |
MX2007005590A (es) | Compuestos del inhibidor glicogeno fosforilasa y sus composiciones farmaceuticas. | |
BRPI0508537A (pt) | moduladores do canal de ìon | |
EA200600078A1 (ru) | Способы и композиции для лечения амилоидных заболеваний | |
MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
WO2006009975A3 (fr) | Utilisation d'histamine et de composes associes pour traiter des troubles de la fonction musculaire | |
BRPI0508550A (pt) | moduladores de canal de ìon | |
WO2005112923A3 (fr) | Dérivés de 5-anilino-4-hétéroarylpyrazole utiles pour le traitement du diabete | |
WO2006113718A3 (fr) | Compositions destinees au traitement des neoplasmes | |
WO2004073615A3 (fr) | Composes de deazaflavine et leurs methodes d'utilisation | |
HK1102626A1 (en) | Compositions and methods for the treatment and prevention of hyperproliferative diseases | |
WO2006091544A3 (fr) | Procedes et compositions de modulation des canaux calciques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |